We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Dressings Deliver Oxygen to Wounds

By HospiMedica staff writers
Posted on 20 Jun 2006
New oxygenated dressings speed wound healing and may offer an alternative to hyperbaric oxygen chamber therapy.

The new technology, named the Oxygenesys topical dissolved oxygen (TDO) system, was developed by AcryMed (Beaverton, OR, USA). More...
The system is designed to allow oxygen to enter the wound via the external surface of the body rather than from capillaries within. Systemic side-effects are therefore avoided and topical dressings are a comforting and readily available approach to wounds for all patients. Studies conducted on human donor skin showed that significant amounts of oxygen were delivered to the wound site and even permeated the skin tissue at a rate that is at least three times higher than the level delivered by blood. The technology was reported at the annual meeting of the Wound Healing Society, held in May 2006 in Scottsdale (AZ, USA).

"The ability to deliver dissolved oxygen directly to a wound site using an easy-to-apply wound dressing represents a real breakthrough in medical science,” said Dr. Bruce Gibbins, founder and chief technical officer at AcryMed. "Our preliminary results are quite promising and by working directly with device manufacturers we expect to have a real solution of this kind on the market soon.”

Wounds require oxygen to heal. For many diabetics and others suffering from chronic wounds, poor circulation of oxygen-rich blood to the wound site (ischemia) can severely retard the healing process. To date, the only viable solution is hyperbaric oxygen therapy, an ongoing treatment in which a patient spends hours in a pressurized chamber breathing oxygen rich air. The therapy typically requires repeated sessions, extended over a period of weeks or months. Hyperbaric oxygen treatment is both expensive and time-consuming, and for those not living close to proper facilities, this treatment may be impractical.



Related Links:
AcryMed

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.